These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35169085)

  • 41. Update on current standard treatments in central nervous system germ cell tumors.
    Kamoshima Y; Sawamura Y
    Curr Opin Neurol; 2010 Dec; 23(6):571-5. PubMed ID: 20885323
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Occurrence of metachronous pure germinomas long after treatment of a mixed germ cell tumor containing yolk sac tumor and germinoma.
    Jinguji S; Okamoto K; Yoshimura J; Yoneoka Y; Ogura R; Saito A; Fujii Y
    J Neurosurg Pediatr; 2013 Jan; 11(1):68-73. PubMed ID: 23082803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: Survival analysis and impact of salvage re-irradiation.
    de Rezende ACP; Weltman E; Chen MJ; Helito JK; de Carvalho ÍT; Sakuraba RK; Silva NS; Cappellano AM; Hamerschlak N
    PLoS One; 2019; 14(12):e0226350. PubMed ID: 31860688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical management of primary central nervous system germ cell tumors.
    Matsutani M
    Semin Oncol; 2004 Oct; 31(5):676-83. PubMed ID: 15497121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relapsing intracranial germ cell tumours warrant retreatment.
    Callec L; Lardy-Cleaud A; Guerrini-Rousseau L; Alapetite C; Vignon L; Chastagner P; Frappaz D; Faure-Conter C
    Eur J Cancer; 2020 Sep; 136():186-194. PubMed ID: 32711377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T2*-based MR imaging (gradient echo or susceptibility-weighted imaging) in midline and off-midline intracranial germ cell tumors: a pilot study.
    Morana G; Alves CA; Tortora D; Finlay JL; Severino M; Nozza P; Ravegnani M; Pavanello M; Milanaccio C; Maghnie M; Rossi A; Garrè ML
    Neuroradiology; 2018 Jan; 60(1):89-99. PubMed ID: 29128947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pooled analysis of clinical trials.
    Fonseca A; Faure-Conter C; Murray MJ; Fangusaro J; Bailey S; Goldman S; Khatua S; Frappaz D; Calaminus G; Dhall G; Nicholson JC; Bouffet E; Bartels U
    Neuro Oncol; 2022 Nov; 24(11):1950-1961. PubMed ID: 35218656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Central nervous system germ cell tumors: controversies in diagnosis and treatment.
    Jubran RF; Finlay J
    Oncology (Williston Park); 2005 May; 19(6):705-11; discussion 711-2, 715-7, 721. PubMed ID: 15971448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Central Nervous System Germ Cell Tumors: A Review of the Literature.
    Kong Z; Wang Y; Dai C; Yao Y; Ma W; Wang Y
    J Child Neurol; 2018 Aug; 33(9):610-620. PubMed ID: 29848146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker.
    Spiekermann M; Belge G; Winter N; Ikogho R; Balks T; Bullerdiek J; Dieckmann KP
    Andrology; 2015 Jan; 3(1):78-84. PubMed ID: 25187505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intracranial germ cells tumour: a single institution experience in Argentina.
    Baroni LV; Oller A; Freytes CS; Sampor CV; Pinto N; Fernandez NP; Rugilo C; Lubieniecki F; Zubizarreta P; Alderete D
    J Neurooncol; 2021 Apr; 152(2):363-372. PubMed ID: 33660119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pediatric primary central nervous system germ cell tumors of different prognosis groups show characteristic miRNome traits and chromosome copy number variations.
    Wang HW; Wu YH; Hsieh JY; Liang ML; Chao ME; Liu DJ; Hsu MT; Wong TT
    BMC Genomics; 2010 Feb; 11():132. PubMed ID: 20178649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment outcome of primary central nervous system germ cell tumors after combined therapy: a report of 23 cases].
    Yang QY; Sun XF; Huang HQ; Zhen ZJ; Xia Y; Cai QQ; Ling JY
    Ai Zheng; 2008 Apr; 27(4):438-41. PubMed ID: 18423134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histopathology of pineal germ cell tumors.
    Vasiljevic A; Szathmari A; Champier J; Fèvre-Montange M; Jouvet A
    Neurochirurgie; 2015; 61(2-3):130-7. PubMed ID: 24726316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Japan Society for Neuro-Oncology guideline on the diagnosis and treatment of central nervous system germ cell tumors.
    Nakamura H; Takami H; Yanagisawa T; Kumabe T; Fujimaki T; Arakawa Y; Karasawa K; Terashima K; Yokoo H; Fukuoka K; Sonoda Y; Sakurada K; Mineharu Y; Soejima T; Fujii M; Shinojima N; Hara J; Yamasaki K; Fujimura J; Yamasaki F; Takahashi M; Suzuki T; Sato I; Nishikawa R; Sugiyama K
    Neuro Oncol; 2022 Apr; 24(4):503-515. PubMed ID: 34671804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment outcome and long-term follow-up of central nervous system germ cell tumor using upfront chemotherapy with subsequent photon or proton radiation therapy: a single tertiary center experience of 127 patients.
    Hong KT; Lee DH; Kim BK; An HY; Choi JY; Phi JH; Cheon JE; Kang HJ; Kim SK; Kim JY; Park SH; Kim IH; Shin HY
    BMC Cancer; 2020 Oct; 20(1):979. PubMed ID: 33036578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors.
    Modak S; Gardner S; Dunkel IJ; Balmaceda C; Rosenblum MK; Miller DC; Halpern S; Finlay JL
    J Clin Oncol; 2004 May; 22(10):1934-43. PubMed ID: 15143087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study.
    da Silva NS; Cappellano AM; Diez B; Cavalheiro S; Gardner S; Wisoff J; Kellie S; Parker R; Garvin J; Finlay J
    Pediatr Blood Cancer; 2010 Mar; 54(3):377-83. PubMed ID: 20063410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma.
    Mishima K; Kato Y; Kaneko MK; Nakazawa Y; Kunita A; Fujita N; Tsuruo T; Nishikawa R; Hirose T; Matsutani M
    Acta Neuropathol; 2006 Jun; 111(6):563-8. PubMed ID: 16718353
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Symptom interval and treatment burden for patients with malignant central nervous system germ cell tumours.
    Hayden J; Murray MJ; Bartels U; Ajithkumar T; Muthusamy B; Penn A; Calaminus G; Nicholson J
    Arch Dis Child; 2020 Mar; 105(3):247-252. PubMed ID: 31594777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.